A study out of the University of California concluded there is a higher risk for teenage boys to develop myocarditis after two doses of an mRNA COVID-19 vaccine, than it is for them to be hospitalized from COVID-19.

Myocarditis is inflammation of the heart that can cause symptoms such as chest pains, irregular heartbeat and trouble breathing. Mild cases can clear up naturally whereas severe cases can result in the need for a heart transplant or death.

Help Support Our FOIA Efforts: Our team is in a back and forth with our government to get access to specific COVID documents that may show government tried to hide treatment options in favor of vaccination campaigns. Help us with clerical and legal fees to obtain these documents by donating today. Click here to Donate.

The link between myocarditis and the vaccine was confirmed in June by the Centers for Disease Control and Prevention (CDC), however they said that the benefits of the vaccine outweigh the risks.

After the CDC confirmation, stories of teenage boys like Jacob Clynick started to be more publicized. Clynick, a 13 year old died, three days after receiving his second dose of the Pfizer vaccine. The preliminary information of his autopsy results showed an enlarged heart, however there was no cause put on his death certificate.

There’s also the story of Fabio Berlingieri’s 17 year old son who took the Pfizer vaccine in order be allowed to attend school and play soccer, even though he had already recovered from COVID. A week after the vaccine his son was complaining of a racing heart and ended up in the ER unable to attend prom.

Further, Ernesto Ramirez, a 16 year old who died five days after receiving his first dose of Pfizer. Enlarged heart was the cause recorded on his death certificate, and his father now speaks out about informed consent.

Research led by epidemiologist Dr. Tracy Høeg found that healthy boys between the ages of 12 and 15 had a 162.2 cases per million chance of having a cardiac adverse event (CAE) such as, myocarditis, after two doses of a mRNA vaccine.

This in comparison to a 26.7 cases per million chance of a healthy boy in this age group being hospitalized with COVID in the next 120 days.

Although Dr. Høeg’s research is still waiting to be peer reviewed and has been criticized for using the Vaccine Adverse Event Reporting System (VAERS) in the design, the Joint Committee on Vaccination and Immunization (JCVI) out of the UK came to similar conclusions.

The JCVI data was referenced in a BBC article to analysis the benefits and risks between the first and second dose of a mRNA vaccine for teenagers.

One takeaway from this data can be that when looking at a teenage boy’s risk of ending up with serious COVID and needing to be in the hospital versus needing to be in the hospital following double vaccination, the rate is expected to be higher from double vaccination.

As of now Norway and the UK are only offering one dose of Pfizer to children 12 to 15 years old, instead of two.

We often hear the extremely rare and heartbreaking story of a child dying of COVID-19, but how often are we hearing about the many cases of children experiencing severe, sometimes life altering, adverse events related to COVID vaccination? How does this change vaccine sentiment?

https://thepulse.one/2021/09/18/fully-vaxxed-teenage-boys-more-likely-to-have-vaccine-induced-heart-problems-than-be-hospitalized-for-covid/